Septerna, Inc. (SEPN) ROE
- 2026-06-30: ROE -6.27%.
- 2026-03-31: ROE -9.52%.
- 2025-12-31: ROE -12.80%.
- 2025-09-30: ROE -15.13%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -6.27% |
| 2026-03-31 | -9.52% |
| 2025-12-31 | -12.80% |
| 2025-09-30 | -15.13% |
| 2025-06-30 | -23.18% |
| 2025-03-31 | -19.78% |
| 2024-12-31 | -17.09% |
| 2024-09-30 | 18.57% |
| 2024-06-30 | 9.83% |
| 2024-03-31 | 1.44% |
| 2023-12-31 | -10.89% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -12.80% |
| 2024-12-31 | -17.09% |
| 2023-12-31 | -10.89% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |